Collaborative Approaches to Implementing Durable Anti-VEGF Solutions in an Evolving Retinal Landscape - CME - Guideline Central

CME

Title
Collaborative Approaches to Implementing Durable Anti-VEGF Solutions in an Evolving Retinal Landscape
Link
Description
Early detection, timely treatment, and appropriate follow-up care can significantly improve outcomes in retinal disease. In rural and underserved communities where access to retina specialists may be limited, primary care clinicians play a critical role in prevention and collaborative management. In this on-demand CME/CE activity, expert faculty will review risk factors for retinal disease and current guideline recommendations aimed at improving screening rates among appropriate patient populations. The program will also highlight advances in treatment and delivery, including the role of anti–vascular endothelial growth factor (VEGF) therapies, as well as team-based strategies to enhance care coordination and optimize visual outcomes across diverse clinical settings.
Target Audience
This activity is designed specifically for primary care clinicians, nurses, eye care specialists (retinal specialists, ophthalmologists, and optometrists), and other members of the healthcare team who care for patients from rural and underserved communities.
Learning Objectives
  • Evaluate the efficacy, safety, and durability outcomes of novel anti-VEGF strategies based on pivotal clinical trial and real-world evidence
  • Apply optimal strategies to identify patients who may benefit from sustained-delivery or extended-interval anti-VEGF regimens, considering clinical characteristics, adherence challenges, and procedural considerations
  • Integrate patient-centered and multidisciplinary approaches to improve treatment access, adherence, and visual outcomes in diverse clinical settings, particularly in underserved and rural populations
Estimated Duration
30 minutes
Delivery Mode
Online
Format
Online Learning
Specialties
Endocrinology, Ophthalmology, Obstetrics and Gynecology, Primary Care
Keywords
diabetes
Disclosures and Disclaimers
This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
Accredited Providers
  • Talem Health
  • RME Collaborative
Commercial Support
  • Genentech
Activity Expiration Date
May 4, 2027
Credit Information
Credit TypeUnits / Unit TypeBoard
AMA PRA Category 1 Credit0.5 CreditsACCME- Accreditation Council for Continuing Medical Education
Nursing0.5 Contact HoursANCC - American Nurses Credentialing Center
Pharmacy0.5 Contact HoursACPE- Accreditation Council for Pharmacy Education
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.